• Cycloheximide as a Precision Tool for Chemoresistance Mechan

  2026-05-27

  Explore how Cycloheximide, a potent protein biosynthesis inhibitor, enables advanced investigation of chemoresistance and apoptosis. This article uniquely bridges translational control with cutting-edge cancer research, highlighting assay design and biological insight.

• CX-4945 (Silmitasertib): Reliable CK2 Inhibition in Cancer &

  2026-05-26

  This article guides researchers through real-world laboratory challenges in CK2-targeted cancer and antiviral assays, showcasing how CX-4945 (Silmitasertib, SKU A8330) delivers reproducible, evidence-backed solutions. Protocol parameters, comparative insights, and data-driven vendor recommendations are provided to optimize cell viability, apoptosis, and host-pathogen studies.

• NSC 87877: Shp2 Inhibitor Workflows for Neuroinflammation Re

  2026-05-26

  NSC 87877 delivers unmatched selectivity as a Shp2 inhibitor, enabling precise dissection of neuroinflammatory and cancer signaling pathways. This guide translates recent mechanistic advances and experimental best practices into actionable protocols and troubleshooting for applied research.

• Dabigatran Etexilate: Advancing Oral Anticoagulation Strateg

  2026-05-25

  The reviewed study highlights dabigatran etexilate as the first oral direct thrombin inhibitor with rapid, predictable anticoagulant effects and no need for routine monitoring, addressing longstanding challenges of traditional therapies. Its clinical efficacy in venous thromboembolism and stroke prevention marks a significant advance over parenteral agents and vitamin K antagonists, with practical implications for both patient care and future research.

• Caspase-3 and ERO1α Mediate Trichothecene-Induced Mitochondr

  2026-05-25

  This study reveals how trichothecene mycotoxins induce hepatotoxicity by triggering caspase-3-mediated cleavage of mitochondrial NDUFS1 and activating ER-localized ERO1α, resulting in excessive ROS accumulation and mitochondrial dysfunction. These mechanistic insights clarify the central pathways linking mycotoxin exposure to oxidative stress and provide a foundation for targeted mitochondrial assays and intervention strategies.

• SEC-seq Reveals VEGF-A Secretion Heterogeneity in MSCs

  2026-05-24

  The reference study introduces SEC-seq, a platform integrating hydrogel nanovial-based cell capture with single-cell transcriptomics to simultaneously measure secreted VEGF-A and gene expression in thousands of mesenchymal stromal cells. This approach uncovers subpopulations with high VEGF-A secretion, offering new insight into cellular heterogeneity and potential targets for cell therapy optimization.

• Protein A/G Magnetic Beads: Precision Tools for Immunoprecip

  2026-05-23

  Protein A/G Magnetic Beads enable high-specificity antibody purification and protein interaction analysis from complex samples. Their recombinant design minimizes non-specific binding, supporting reproducible immunoprecipitation workflows. APExBIO’s K1305 beads provide robust performance for Ch-IP and Co-IP applications.

• Amt-1: Dual Nrf2/HO-1 and M2-Targeted Antiviral Defense in I

  2026-05-22

  This study introduces Amt-1, an adamantane derivative, as a dual-acting antiviral against influenza A virus (IAV). By combining M2 ion channel inhibition with Nrf2/HO-1-mediated immunomodulation, Amt-1 addresses drug resistance and excessive inflammation, offering a novel host-targeted strategy for IAV therapy.

• Phosphoproteomic Remodeling in RCC Under Chronic Cabozantini

  2026-05-22

  This study leverages quantitative phosphoproteomics to dissect how acute and chronic cabozantinib exposure remodels phosphorylation networks and cell motility in renal cell carcinoma (RCC). The work provides critical systems-level insight into timescale-dependent adaptation to multi-kinase inhibition, informing experimental strategy and resistance modeling.

• TG003 Cdc2-like Kinase Inhibitor: Splicing Modulation in Act

  2026-05-21

  TG003 empowers researchers to precisely study and modulate alternative splicing by selectively inhibiting Clk family kinases. Its proven role in overcoming platinum resistance and optimizing exon-skipping therapy uniquely positions it as a translational tool for both basic and disease-focused RNA research.

• Dextrose (D-glucose): Powering Precision Tumor Immunometabol

  2026-05-21

  Explore how Dextrose (D-glucose) enables high-fidelity modeling of hypoxia-driven immunometabolism in the tumor microenvironment, bridging mechanistic insight with practical guidance for translational researchers. This article contextualizes APExBIO’s Dextrose as a gold-standard metabolic substrate, synthesizes evidence from landmark reviews, and provides actionable protocol and strategy recommendations for advancing metabolic research in cancer.

• Isoprinosine in Antiviral Immunotherapy: Integrating Viral E

  2026-05-20

  Explore the multifaceted potential of Isoprinosine as an immunomodulatory agent and antiviral immunotherapy tool. This article uniquely connects herpesvirus nuclear egress mechanisms with Isoprinosine’s clinical and experimental applications.

• Deferasirox: Iron Chelation and Metabolic Adaptation in Canc

  2026-05-20

  This thought-leadership article explores Deferasirox as an oral iron chelator at the intersection of iron overload therapy and cancer metabolism research. Integrating mechanistic insights, new evidence on nutrient sensing, and translational guidance, it offers a bridge between bench and bedside for researchers seeking to harness iron modulation against tumor growth and metabolic stress.

• Digoxin (SKU B7684): Reliable Solutions for Cardiac & Antivi

  2026-05-19

  This article delivers evidence-driven guidance for deploying Digoxin (SKU B7684) in cell viability, cardiac contractility, and antiviral research. Drawing on peer-reviewed literature and validated product data, we address real-world laboratory challenges—from experimental design to vendor selection—ensuring high reproducibility, sensitivity, and workflow efficiency with APExBIO’s Digoxin.

• Astrocytic GAT-3 Modulates Synaptic Transmission in Dentate

  2026-05-19

  This study reveals that astrocytic GAT-3 critically regulates synaptic transmission and memory formation in the dentate gyrus via calcium-dependent signaling. These findings establish a mechanistic link between glial GABA transport, hippocampal plasticity, and cognitive function, advancing our understanding of astrocyte-neuron interactions.

724 records 19/49 page Previous Next First page 上5页 1617181920 下5页 Last page